Literature DB >> 12562043

Chronic disease self-management and adherence to HIV medications.

Allen L Gifford1, Erik J Groessl.   

Abstract

Although it is widely recognized that potent antiretroviral therapies have transformed HIV from an acute to a chronic illness, it is less often recognized that with this change, a different model of care is appropriate. People living with chronic HIV must function independently, taking personal long-term, day-to-day responsibility for care. The role of doctors and the healthcare system is to help them do this. The authors present a conceptual framework for the self-management of chronic HIV disease and discuss the components of an HIV self-management program. The ability to take antiretroviral medications well and consistently is a key part of self-management but should be nested within an array of important skills, including symptom-management skills, goal setting and planning, communication, and accessing information and resources.

Entities:  

Mesh:

Year:  2002        PMID: 12562043     DOI: 10.1097/00126334-200212153-00016

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  36 in total

Review 1.  Impact of community-based support services on antiretroviral treatment programme delivery and outcomes in resource-limited countries: a synthetic review.

Authors:  Edwin Wouters; Wim Van Damme; Dingie van Rensburg; Caroline Masquillier; Herman Meulemans
Journal:  BMC Health Serv Res       Date:  2012-07-09       Impact factor: 2.655

Review 2.  A review of the use of complementary and alternative medicine and HIV: issues for patient care.

Authors:  Ava Lorenc; Nicola Robinson
Journal:  AIDS Patient Care STDS       Date:  2013-09       Impact factor: 5.078

3.  A longitudinal investigation of the impact of life stress on HIV treatment adherence.

Authors:  Kathryn A Bottonari; Steven A Safren; John R McQuaid; Chiu-Bin Hsiao; John E Roberts
Journal:  J Behav Med       Date:  2010-06-25

4.  Identifying preferences for mobile health applications for self-monitoring and self-management: focus group findings from HIV-positive persons and young mothers.

Authors:  Nithya Ramanathan; Dallas Swendeman; W Scott Comulada; Deborah Estrin; Mary Jane Rotheram-Borus
Journal:  Int J Med Inform       Date:  2012-06-14       Impact factor: 4.046

5.  Implementing a Pre-Exposure Prophylaxis Intervention for Safer Conception among HIV Serodiscordant Couples: Recommendations for Health Care Providers.

Authors:  Mari-Lynn Drainoni; Dea L Biancarelli; Ashley A Leech; Meg Sullivan; Angela R Bazzi
Journal:  J Health Dispar Res Pract       Date:  2018

Review 6.  Common elements in self-management of HIV and other chronic illnesses: an integrative framework.

Authors:  Dallas Swendeman; Barbara L Ingram; Mary Jane Rotheram-Borus
Journal:  AIDS Care       Date:  2009-10

7.  Structures of care in the clinics of the HIV Research Network.

Authors:  Baligh R Yehia; Kelly A Gebo; Perrin B Hicks; P Todd Korthuis; Richard D Moore; Michelande Ridore; William Christopher Mathews
Journal:  AIDS Patient Care STDS       Date:  2008-12       Impact factor: 5.078

8.  Mg supplementation attenuates ritonavir-induced hyperlipidemia, oxidative stress, and cardiac dysfunction in rats.

Authors:  I Tong Mak; Jay H Kramer; Xi Chen; Joanna J Chmielinska; Christopher F Spurney; William B Weglicki
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-18       Impact factor: 3.619

9.  Short-term physical and emotional health outcomes of public sector ART in the Free State province of South Africa.

Authors:  Edwin Wouters; Herman Meulemans; H C J Van Rensburg; J C Heunis; Dimitri Mortelmans
Journal:  Qual Life Res       Date:  2007-11       Impact factor: 4.147

10.  Patient activation and improved outcomes in HIV-infected patients.

Authors:  Rebecca Marshall; Mary Catherine Beach; Somnath Saha; Tomi Mori; Mark O Loveless; Judith H Hibbard; Jonathan A Cohn; Victoria L Sharp; P Todd Korthuis
Journal:  J Gen Intern Med       Date:  2013-05       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.